Outcomes of Adjuvant Oral versus Intravenous Fluoropyrimidines for High-Risk Stage II or Stage III Colon Adenocarcinoma: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study

Objective: We conducted this propensity score (PS)-matched, nationwide, population-based cohort study to estimate the effects of adjuvant oral or intravenous (IV) fluoropyrimidine in patients with high-risk stage II or III colon adenocarcinoma. Design: Using PS matching, we minimized the confounding...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jiaqiang, Yen, Yu-Chun, Qin, Lei, Chang, Chia-Lun, Yuan, Kevin Sheng-Po, Wu, Alexander T.H., Wu, Szu-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196259/
https://www.ncbi.nlm.nih.gov/pubmed/32368298
http://dx.doi.org/10.7150/jca.42404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196259/
https://www.ncbi.nlm.nih.gov/pubmed/32368298
http://dx.doi.org/10.7150/jca.42404

Ejemplares similares